EE81 Cost-Effectiveness of CDK 4/6I for the Treatment of Postmenopausal Patients With Advanced Breast Cancer HR-Positive, HER2-Negative From the Point of View of the Payer of the Public Health System in Panama
乳腺癌
医学
肿瘤科
内科学
成本效益
妇科
癌症
风险分析(工程)
作者
O. Castillo,G. Sinta
出处
期刊:Value in Health [Elsevier BV] 日期:2023-12-01卷期号:26 (12): S66-S66